Venture Life Group PLC UltraDEX Patent Grants and Distribution Update (8825F)
23 May 2017 - 4:00PM
UK Regulatory
TIDMVLG
RNS Number : 8825F
Venture Life Group PLC
23 May 2017
Venture Life Group plc
("Venture Life" or the "Company")
UltraDEX Patent Grants and Distribution Update
Venture Life (AIM: VLG), the international consumer self-care
group focused on developing, manufacturing and commercialising
products for the ageing population, announces it has been granted
patents in Japan, Indonesia, Australia and Mexico for its UltraDEX
Sensitive range. These new recent patent grants add to the existing
patents already granted in the USA, UK, South Africa and New
Zealand for this innovative product range. Venture Life also has
patent applications pending in many other jurisdictions, including
the EU.
The aforementioned range of products contains a multicomponent
composition and includes specific ingredients to reduce sensitivity
and provide 12 hours of fresh breath. The UltraDEX range of
products is manufactured at Venture Life's development facility in
Italy.
Domestically, Venture Life's has agreed with Boots Chemists
("Boots") to list two new additional UltraDEX products, increasing
the range of UltraDEX products stocked in store from eight to ten.
As a result of these new listings and further distribution gains,
shelf space presence will further increase from July onwards. The
Board believes this further validates Venture Life's relationship
with this key partner in the UK, and shows the continuing strength
of the UltraDEX brand.
Jerry Randall, CEO of Venture Life, commented: "In Q1 2017, we
ran a second successful UK advertising campaign that saw the
UltraDEX brand once again featured on tube cards and radio stations
across London and the South East, alongside promotional activity in
key retailers. We are planning further activities in 2017 combined
with a continued brand refresh and future product development. I am
particularly delighted to see the further validation of the
UltraDEX range in Boots, listing two additional products in the
range. The progress we are making is testament to our strong
leadership team and excellent support network, and reaffirms our
strategic direction for the brand that we set out at the time of
its acquisition last year."
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014 (MAR).
For further information please contact:
+44 (0) 1344
Venture Life Group PLC 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited +44 (0) 20
(Nominated Adviser and Joint Broker) 3861 6625
Matthew Johnson / Edward Hutton / Margarita
Mitropoulou (Corporate Finance)
Bob Pountney / John Howes (Corporate
Broking)
Turner Pope Investments (TPI) Ltd (Joint +44 (0) 20
Broker) 3621 4120
James Pope / Ben Turner
Walbrook PR venturelife@walbrookpr.com
or + 44 (0) 20 7933 8780
Anna Dunphy / Paul McManus +44 (0) 7980 541 893 / +44
(0) 7876 741 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the ageing population. The Group's product portfolio includes
some key products such as the UltraDEX oral care products range,
food supplements for lowering cholesterol and maintaining brain
function, medical devices for women's intimate healthcare and
haemorrhoids and dermo-cosmetics for addressing the signs of
ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies supplied by the Group's international distribution
partners.
Through its development and manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the medical devices and cosmetic
sectors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFVEEFIFFID
(END) Dow Jones Newswires
May 23, 2017 02:00 ET (06:00 GMT)
Venture Life (LSE:VLG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2023 to Apr 2024